Top Markets
Coin of the day
SpectraScience, Inc. SpectraScience, Inc.

SpectraScience, Inc.

SCIE
株式のランク #42097
SpectraScience, Inc. specializes in creating and distributing an advanced... SpectraScience, Inc. specializes in creating and distributing an advanced technological platform designed for the immediate classification of tissue as normal, pre-cancerous, or cancerous, thereby bypassing the requirement for invasive physical biopsies. This innovative approach is accessible in the United States, Europe, and other global regions. The company's product line includes the WavSTAT3 optical biopsy system, which assesses colon tissue for normal, pre-cancerous, or cancerous conditions without surgical removal. Another key offering is the WavSTAT4 optical biopsy system, a diagnostic tool for the colon that employs UV laser light to optically scan and analyze tissue, enabling physicians to make instant diagnoses during endoscopic cancer screenings. Additionally, SpectraScience provides related accessories such as mobile consoles and disposable forceps. The company is also actively developing an application for esophageal diagnostics, focused on identifying pre-cancerous and cancerous tissue formations. Founded in 1983, the company operated as GV Medical, Inc. until it adopted the name SpectraScience, Inc. in October 1992, and is headquartered in San Diego, California.
株価
$0.000001
最終同期: 2025-08-26
時価総額
$4.92K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 SpectraScience, Inc. (SCIE)

カテゴリー

SpectraScience, Inc.(SCIE)の営業利益率
2026 時点の営業利益率 TTM: 0.00%
SpectraScience, Inc. の最新の財務報告と株価によると、現在の営業利益率(TTM)は 0.00% です。2026 年末時点では 0.00% でした。
SpectraScience, Inc. の営業利益率の履歴(2026 から 2026)
各年末の営業利益率
営業利益率 変化
提供された日付のデータは十分ではありません。
同業他社の営業利益率
企業 営業利益率 営業利益率の差
18.56% -
IE
0.00% -
CN
0.00% -
CH
0.00% -
CH
0.00% -
CN
企業の営業利益率とは?
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。